BioNTech And Pfizer To Begin Clinical Trial For Covid-19 Vaccine
MAINZ, GERMANY - APRIL 22: The headquarters of German immunotherapy company BioNTech stands on April 22, 2020 in Mainz, Germany. BioNTech and U.S. pharmaceutical giant Pfizer announced today that German authorities have granted them approval to begin clinical trials for BioNTech's BNT162, a possible vaccine against Covid-19. BioNTech will conduct the trial in Germany with 200 participants while Pfizer will conduct its trial in the United States once regulatory authorities grant the trial there. (Photo by Thomas Lohnes/Getty Images)
PURCHASE A LICENCE
How can I use this image?
₹14,000.00
INR
Getty ImagesBioNTech And Pfizer To Begin Clinical Trial For Covid-19 Vaccine, News Photo
BioNTech And Pfizer To Begin Clinical Trial For Covid-19 Vaccine Get premium, high resolution news photos at Getty ImagesProduct #:1220435202
BioNTech And Pfizer To Begin Clinical Trial For Covid-19 Vaccine Get premium, high resolution news photos at Getty ImagesProduct #:1220435202₹23,000₹7,000
Getty Images
In stockDETAILS
Restrictions:
Contact your local office for all commercial or promotional uses.
Credit:
Editorial #:
1220435202
Collection:
Getty Images News
Date created:
22 April, 2020
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Getty Images Europe
Object name:
_dsc0529_lohnes_20200422105137798.jpg
Max file size:
8256 x 5504 px (69.90 x 46.60 cm) - 300 dpi - 8 MB
- BioNTech,
- Business,
- Business Finance and Industry,
- COVID-19,
- COVID-19 Vaccine,
- Economy,
- Finance and Economy,
- Germany,
- Headquarters,
- Healthcare And Medicine,
- Horizontal,
- Illness,
- Immunotherapy,
- Infectious Disease,
- Mainz,
- Pandemic - Illness,
- Photography,
- Research,
- Rhineland-Palatinate,
- Science and Technology,
- Vaccination,